General Information of the Compound
Compound ID
CP0036050
Compound Name
2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide
    Show/Hide
Synonyms
AZD-1152-HQPA
Barasertib
    Show/Hide
Structure
Formula
C26H30FN7O3
Molecular Weight
507.57
Canonical SMILES
CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1
    Show/Hide
InChI
InChI=1S/C26H30FN7O3/c1-2-34(10-11-35)9-4-12-37-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(36)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17,35H,2,4,9-12,15H2,1H3,(H,30,36)(H2,28,29,31,32,33)
    Show/Hide
InChIKey
QYZOGCMHVIGURT-UHFFFAOYSA-N
Physicochemical Property
logP
3.4999
Rotatable Bonds
13
Heavy Atom Count
37
Polar Areas
128.29
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
8
Complexity
37

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16007391
SID: 24383544
ChEMBL ID
CHEMBL215152
Clinical Information about the Compound
Drug 1 ( AZD-1152-HQPA )
Drug Name AZD-1152-HQPA
Indication
Solid tumour/cancer
Phase 1
Target(s)
Aurora kinase B (AURKB)
Modulator